Founded in the UK in late 2023, RhazesAI is an end-to-end virtual assistant that aims to augment the capabilities of clinicians so they can spend more time on the things that matter.
Rhazes combines clinical decision support with intelligent scribing, taking care of over 90% of the traditional required paperwork to help accelerate diagnosis and management planning.
To launch its operations in the UK market, Rhazes faced a multifaceted challenge requiring meticulous attention to investor and customer expectations while simultaneously planning for future scalability.
Satisfying the rigorous diligence requirements of both investors and customers necessitated a robust strategy that balanced immediate needs with long-term objectives.
Ensuring GDPR compliance from the outset was imperative, while also laying the groundwork for future expansion into regions governed by other data protection regulations such as HIPAA and PIPEDA.
Rhazes embarked on a journey towards building and maintaining a GDPR-compliant application, recognizing its necessity for maintaining a strong reputation and building stakeholder trust.
Partnering with MedStack allowed Rhazes to adhere to stringent compliance standards at a fraction of the time and cost.
MedStack’s built-in, managed security program and proactive approach to risk management were also integral to Rhazes’ decision to partner with MedStack.
Key protocols, including managing outages, deploying timely alerts, and maintaining comprehensive backups, would allow Rhazes to fortify its infrastructure against potential disruptions while ensuring continuity and reliability for their users.
In a span of 10 months, Rhazes went from an idea to a fully launched product, marking a remarkable journey from conception to realization and showcasing the efficiency of deploying on MedStack.
“The MedStack team went above and beyond to help us navigate the maze of compliance,” says Peter Sarvari, Co-Founder and CTO at Rhazes.
“From the very beginning, they have been devoted to supporting us along our compliance journey. Their knowledgeable team and their timely and professional support really gives us peace of mind when it comes to regulatory compliance and cybersecurity.”
Since unveiling its product to the market in early 2024 the company has been garnering significant press and VC attention. It was recently recognized as one of the top 5% of startups worldwide by Focal and was the winner of the audience vote at the 2024 Web Summit Qatar PITCH competition.
Rhazes has been acquiring new customers at a rapid pace and is already set to surpass 1,000 users.
Stay up to date on the latest industry news and get MedStack product updates right in your inbox.
Learn how MedStack can help you.